Upgrades by analysts, especially with a significant increase in price target, typically lead to positive short-term price movements as they reflect a positive change in the company's outlook. The upgrade from Market Perform to Outperform suggests a strong confidence in Tandem Diabetes Care's future performance, potentially attracting more investors.